{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:05:13Z","timestamp":1784909113255,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.exphem.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T11:59:37Z","timestamp":1653566377000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["RUNX1 Inhibition Using Lipid Nanoparticle-Mediated Silencing RNA Delivery as an Effective Treatment for Acute Leukemias"],"prefix":"10.1016","volume":"112-113","author":[{"given":"Kohei","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiho","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehisa","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Ishihara-Sugano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-1826","authenticated-orcid":false,"given":"Susumu","family":"Goyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2022.05.001_bib0001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jcp.21950","article-title":"Core binding factor at the crossroads: determining the fate of the HSC","volume":"222","author":"Link","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2022.05.001_bib0002","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.05.001_bib0003","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2016-12-689109","article-title":"Runx transcription factors in the development and function of the definitive hematopoietic system","volume":"129","author":"de Bruijn","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.05.001_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-981-10-3233-2_11","article-title":"RUNX1-ETO Leukemia","volume":"962","author":"Lin","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.exphem.2022.05.001_bib0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12185-011-0858-z","article-title":"Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects","volume":"94","author":"Goyama","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2022.05.001_bib0006","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/sj.onc.1207779","article-title":"Point mutations in the RUNX1\/AML1 gene: another actor in RUNX leukemia","volume":"23","author":"Osato","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2022.05.001_bib0007","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1038\/onc.2014.305","article-title":"Posttranslational modifications of RUNX1 as potential anticancer targets","volume":"34","author":"Goyama","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2022.05.001_bib0008","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/leu.2015.58","article-title":"Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice","volume":"29","author":"Hyde","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2022.05.001_bib0009","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.20160927","article-title":"RUNX1 cooperates with FLT3-ITD to induce leukemia","volume":"214","author":"Behrens","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2022.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood-2017-03-775536","article-title":"RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia","volume":"130","author":"Choi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.05.001_bib0011","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1172\/JCI68557","article-title":"Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells","volume":"123","author":"Goyama","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2022.05.001_bib0012","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.celrep.2013.08.020","article-title":"Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1","volume":"4","author":"Ben-Ami","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2022.05.001_bib0013","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1172\/JCI91788","article-title":"Genetic regulation of the RUNX transcription factor family has antitumor effects","volume":"127","author":"Morita","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2022.05.001_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107688","article-title":"Acute myeloid leukemia iPSCs reveal a role for RUNX1 in the maintenance of human leukemia stem cells","volume":"31","author":"Wesely","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2022.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nature Rev Mater"},{"key":"10.1016\/j.exphem.2022.05.001_bib0016","first-page":"1033","article-title":"Lipid composition design of lipid nanoparticles by Bayesian optimization for high-efficiency gene delivery to peripheral blood mononuclear cells","volume":"4","author":"Nozaki","year":"2021","journal-title":"J Nanomed"},{"key":"10.1016\/j.exphem.2022.05.001_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood-2020-139020","article-title":"Tumor-tropic liposome-mediated therapeutic delivery of mRNA for T cell malignancies","volume":"136","author":"Saito","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.05.001_bib0018","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1038\/s41598-019-44496-6","article-title":"Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms","volume":"9","author":"Tamura","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2022.05.001_bib0019","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.2951","article-title":"Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing","volume":"32","author":"Heck","year":"2014","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.exphem.2022.05.001_bib0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.exphem.2022.05.001_bib0021","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1182\/blood-2002-05-1589","article-title":"AML1\/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells","volume":"101","author":"Heidenreich","year":"2003","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22002569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22002569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:37:33Z","timestamp":1759567053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X22002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":21,"alternative-id":["S0301472X22002569"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2022.05.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RUNX1 Inhibition Using Lipid Nanoparticle-Mediated Silencing RNA Delivery as an Effective Treatment for Acute Leukemias","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}